The chronic disease explosion: artificial bang or empirical whimper?
BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i1312 (Published 15 March 2016) Cite this as: BMJ 2016;352:i1312- Kimberlyn McGrail, associate professor1,
- Ruth Lavergne, postdoctoral fellow2,
- Steven Lewis, president3 4
- 1School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada V6T 1Z3
- 2McGill University Montreal
- 3Access Consulting Saskatoon
- 4Simon Fraser University Burnaby
- Correspondence to: Kimberlyn McGrail kim.mcgrail{at}ubc.ca
- Accepted 26 February 2016
The World Health Organization defines health as the complete state of physical, mental, and social wellbeing. A recent paper from the Global Burden of Disease study suggests only 4% of the world’s population is now free of disease.1 If true, health is not the norm but an anomalous state, and only a tiny fraction of the world’s population could meet the WHO’s exacting standard. The main culprit, chronic disease, is now so common that healthcare systems are increasingly focused on people with more than one condition. Multimorbidity, recently described as the “most common chronic condition,”2 affects at least half of the population over age 65.3
The effect of chronic conditions, and particularly multimorbidity, on healthcare expenditures is striking. Patients with chronic conditions now account for most consultations in primary care4 and an estimated 84% of total spending in the US.5 Not surprisingly, costs are related to the number of chronic conditions. Compared with people with no chronic conditions, costs are nearly three times greater for people with one condition, five times greater for those with two, and eight times greater for those with three.5
Moreover, recent reports suggest that the number of people with chronic disease is rising faster than previously projected.5 The combination of increasing prevalence and the cost of treatment has led to widespread consensus that dealing with and managing chronic conditions is the single largest challenge facing healthcare systems in the developed world.4
This is a gloomy scenario, but only if reported increases reflect real health problems that can benefit from enhanced diagnosis and treatment. There has been little or no critical assessment of the pace of epidemiological change, the plausibility of proposed explanations …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.